COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS AFFECTED BY CHRONIC KIDNEY DISEASE IN ITALY

被引：0
|
作者：
Di Costanzo, A. [1 ]
Uster, A. [2 ]
Vassallo, C. [1 ]
Fiorentino, F. [1 ]
机构：
[1] IQVIA Solut Srl, Milan, Italy
[2] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE117
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [41] THE COST-EFFECTIVENESS OF PATIROMER FOR THE TREATMENT OF HYPERKALAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HEART FAILURE IN THE UK
    Ward, T.
    Baxter, G.
    Serna, Ramirez de Arellano A.
    VALUE IN HEALTH, 2022, 25 (01) : S43 - S43
  • [42] Cost-effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes
    Nguyen, Bao-Ngoc
    Mital, Shweta
    Bugden, Shawn
    Nguyen, Hai V.
    DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 3030 - 3039
  • [43] THE COST-EFFECTIVENESS OF PATIROMER FOR THE TREATMENT OF HYPERKALAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HEART FAILURE IN IRELAND
    Ward, T.
    Serna, Ramirez de Arellano A.
    Quinn, C.
    VALUE IN HEALTH, 2022, 25 (01) : S95 - S95
  • [44] COST-EFFECTIVENESS ANALYSIS OF USING KETOANALOGUES OF ESSENTIAL AMINOACIDS IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN KAZAKHSTAN
    Avdeyev, A.
    Gulyaev, A.
    Akhmedullin, R.
    VALUE IN HEALTH, 2023, 26 (12) : S73 - S73
  • [45] Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial
    Reifsnider, Odette S.
    Kansal, Anuraag R.
    Wanner, Christoph
    Pfarr, Egon
    Koitka-Weber, Audrey
    Brand, Sarah B.
    Stargardter, Matthew
    Wang, Cheng
    Kuti, Effie
    Ustyugova, Anastasia
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (06) : 796 - 806
  • [46] Cost-effectiveness of ponatinib in chronic myeloid leukemia in Italy
    Lucioni, Carlo
    Iannazzo, Sergio
    Mazzi, Silvio
    Saporiti, Giorgia
    Chiroli, Silvia
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2015, 2 (01) : 1 - 16
  • [47] The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
    Yarnoff, Benjamin O.
    Hoerger, Thomas J.
    Simpson, Siobhan K.
    Leib, Alyssa
    Burrows, Nilka R.
    Shrestha, Sundar S.
    Pavkov, Meda E.
    BMC NEPHROLOGY, 2017, 18
  • [48] The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
    Benjamin O. Yarnoff
    Thomas J. Hoerger
    Siobhan K. Simpson
    Alyssa Leib
    Nilka R. Burrows
    Sundar S. Shrestha
    Meda E. Pavkov
    BMC Nephrology, 18
  • [49] A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy
    Colombo, Giorgio L.
    Gaeta, Giovanni B.
    Vigano, Mauro
    Di Matteo, Sergio
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2011, 3 : 37 - 46
  • [50] Population-Wide Screening for Chronic Kidney Disease A Cost-Effectiveness Analysis
    Cusick, Marika M.
    Tisdale, Rebecca L.
    Chertow, Glenn M.
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (06) : 788 - +
12345